The global point-of-care diagnostics market is expected to reach USD 77.8 billion by 2028 from an estimated USD 49.7 billion in 2023, at a CAGR of 9.4% from 2023 to 2028.
Key Growth Influencing Factors:
- Technological Advancements
- Expansion of Test Menu
- Personalized Medicine and Precision Diagnostics
- Integration with Telehealth and Remote Monitoring
- Point-of-Care Testing in Non-Traditional Settings
- Regulatory Landscape and Quality Assurance
- Point-of-Care Diagnostics in Global Health Initiatives
- Data Analytics and Artificial Intelligence (AI)
- Point-of-Care Diagnostics in Home Healthcare
- Collaboration and Partnerships
To know about the assumptions considered for the study download the pdf brochure
Technological Advancements:
Continued advancements in technology, including miniaturization, automation, and connectivity, will drive innovation in point-of-care diagnostic devices. Emerging technologies such as microfluidics, lab-on-a-chip, and smartphone-based diagnostics will enable rapid, portable, and user-friendly testing solutions for decentralized healthcare settings.
Expansion of Test Menu:
There will be a growing demand for point-of-care diagnostic tests across a wide range of clinical applications, including infectious diseases, cardiovascular markers, cancer biomarkers, and metabolic disorders. Manufacturers will focus on expanding the test menu to address unmet clinical needs and provide comprehensive diagnostic solutions at the point of care.
Personalized Medicine and Precision Diagnostics:
The shift towards personalized medicine and precision diagnostics will drive the development of point-of-care tests for targeted therapy selection, treatment monitoring, and patient stratification. Biomarker-based assays, companion diagnostics, and pharmacogenomic testing at the point of care will enable more tailored and effective patient management strategies.
Integration with Telehealth and Remote Monitoring:
Point-of-care diagnostics will increasingly integrate with telehealth platforms and remote monitoring systems to enable seamless virtual care delivery and remote patient management. Connected diagnostic devices, cloud-based data sharing, and telemedicine software will facilitate remote test ordering, result reporting, and clinical decision support for healthcare providers and patients.
Point-of-Care Testing in Non-Traditional Settings:
Point-of-care testing will expand beyond traditional healthcare settings, including pharmacies, workplaces, schools, and community outreach programs. Rapid diagnostic tests for infectious diseases, wellness screening, and chronic disease management will be deployed in non-clinical settings to improve access to healthcare services and facilitate early intervention.
Regulatory Landscape and Quality Assurance:
Regulatory agencies will play a critical role in ensuring the safety, efficacy, and quality of point-of-care diagnostic tests through robust regulatory oversight, quality assurance standards, and harmonized regulations. Manufacturers will need to comply with regulatory requirements and obtain timely approvals for new products and test platforms to enter the market.
Point-of-Care Diagnostics in Global Health Initiatives:
Point-of-care diagnostics will play a vital role in addressing global health challenges, including infectious disease outbreaks, antimicrobial resistance, and maternal and child health. Portable and affordable diagnostic tests for resource-limited settings will support disease surveillance, outbreak detection, and timely intervention in underserved communities worldwide.
Data Analytics and Artificial Intelligence (AI):
Data analytics and AI-driven algorithms will enhance the diagnostic capabilities of point-of-care testing devices, enabling real-time data interpretation, decision support, and predictive analytics. AI-powered diagnostic algorithms will assist healthcare providers in interpreting test results, identifying patterns, and predicting patient outcomes to facilitate more informed clinical decisions at the point of care.
Point-of-Care Diagnostics in Home Healthcare:
There will be a growing trend towards home-based point-of-care diagnostics for self-testing, chronic disease management, and remote monitoring of patients with complex medical conditions. User-friendly test kits, connected devices, and telehealth platforms will empower patients to monitor their health at home and actively participate in their care management.
Collaboration and Partnerships:
Collaboration and partnerships between industry stakeholders, including manufacturers, healthcare providers, payers, and regulatory agencies, will drive innovation and market growth in the point-of-care diagnostics industry. Strategic alliances, research collaborations, and technology transfer agreements will foster knowledge sharing, resource pooling, and collective efforts to address healthcare challenges and improve patient outcomes through point-of-care testing.
Related Reports:
Point of Care Diagnostics Market by Product (Glucose, HIV, Hep C, HPV, Hematology, Pregnancy), Platform (Microfluidic, Dipstick, RT-PCR, INAAT), Sample(Blood, Urine), Purchase (OTC, Rx), End User (Pharmacy, Hospitals, Home Care) — Global Forecast to 2028
